HIGHLIGHTS
- who: Jacques Balosso from the FranceFrance have published the research work: A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial, in the Journal: (JOURNAL) of July/20,/2016
- what: In the present study, two groups of indications known for their intrinsic radioresistance and for which the medical data obtained in the pioneering centers for carbon ion therapy are the most documented will be considered: sarcomas and adenoid cystic carcinomas of the head and neck . The aim . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.